Nutrition intervention to decrease symptoms in patients with advanced heart failure

Res Nurs Health. 2013 Apr;36(2):120-45. doi: 10.1002/nur.21524. Epub 2013 Jan 17.

Abstract

For a majority of patients with advanced heart failure, there is a need for complementary, non-pharmacologic interventions that could be easily implemented by health care providers to provide palliative care. Three major pathologic pathways underlying heart failure symptoms have been identified: fluid overload, inflammation, and oxidative stress. Prior research has demonstrated that three nutrients-sodium, omega-3 fatty acids, and lycopene-can alter these pathologic pathways. Therefore, the purposes of this study are to test the effects of a 6-month nutrition intervention of dietary sodium reduction combined with supplementation of lycopene and omega-3 fatty acids on heart failure symptoms, health-related quality of life, and time to heart failure rehospitalization or all-cause death. The aims of this double blind-placebo controlled study are (1) to determine the effects of a 6-month nutrition intervention on symptom burden (edema, shortness of air, and fatigue) and health-related quality of life at 3 and 6 months, and time to heart failure rehospitalization or all-cause death over 12 months from baseline; (2) compare dietary sodium intake, inflammation, and markers of oxidative stress between the nutrition intervention group and a placebo group at 3 and 6 months; and (3) compare body weight, serum lycopene, and erythrocyte omega-3 index between the nutrition intervention group and a placebo group at 3 and 6 months. A total of 175 patients with advanced heart failure will be randomized to either the nutrition intervention or placebo group.

Publication types

  • Editorial
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Biomarkers / blood
  • Carotenoids / blood
  • Carotenoids / therapeutic use
  • Diet, Sodium-Restricted
  • Dietary Supplements
  • Dinoprost / analogs & derivatives
  • Dinoprost / blood
  • Fatty Acids, Omega-3 / therapeutic use
  • Female
  • Heart Failure / diet therapy*
  • Hospitalization / statistics & numerical data
  • Humans
  • Inflammation / diet therapy
  • Lycopene
  • Male
  • Malondialdehyde / blood
  • Middle Aged
  • Oxidative Stress
  • Palliative Care
  • Prospective Studies
  • Quality of Life*
  • Treatment Outcome
  • Uric Acid / blood

Substances

  • Biomarkers
  • Fatty Acids, Omega-3
  • Uric Acid
  • 8-epi-prostaglandin F2alpha
  • Carotenoids
  • Malondialdehyde
  • Dinoprost
  • Lycopene